The Value of Neuroimaging in Dementia Diagnosis - Part 1

The Value of Neuroimaging in Dementia Diagnos...

Up next

Prevalence of CTE at Death in National Football League Players

Dr. Shuvro Roy and Dr. Daniel Daneshvar discussed the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia. Show citation: Daneshvar DH, Nowinski CJ, Abdolmohammadi B, et al. Prevalence of chronic traumatic encephalopathy ...  Show more

Clinical Manifestations of Primary CNS T-Cell Lymphoma

Dr. Kait Nevel and Dr. Katharina Schmidbauer discuss primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease. Show citation: Schmidbauer KJ, Karschnia P, Kaulen LD, et al. Clinical Manifestations of ...  Show more

Recommended Episodes

Alzheimer Disease: Diffusion Tensor MRI and amyloid PET
Radiology Podcast | RSNA

Dr. Manisha Bahl interviews Dr. Jeffrey Prescott. Diffuse Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. Prescott et al. Radiology 2022; 302:143–150.  

Improving Cognitive Function
Nutrition Facts with Dr. Greger

A look at some studies on the prevention and treatment of dementia. This episode features audio from: How Much Exercise Does It Take to Improve Aging Cognitive Function? Cognitive Stimulation, Music Therapy, and Cryostimulation to Improve Cognitive Function Visit the video pages ...  Show more

Dr Iracema Leroi on a hearing and vision rehabilitation intervention for people with dementia
The Lancet Healthy Longevity in conversation with

Dr Iracema Leroi discusses the SENSE-Cog trial on the effects of a hearing and vision rehabilitation and support programme on quality of life in people living with dementia.Read the full article: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00141-7/fulltext?dg ...  Show more

Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
JAMA Clinical Reviews

In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.

<stron ...

  Show more